Clover Health Investments Corp. (CLOV) was up 5.11% at $9.26 at the time of the last pre-market check. CLOV stock closed the last session at $8.81, up 9.17% or $0.74. For the day, CLOV stock fluctuated between $8.0815 and $8.84. CLOV stock exchanged 25.82 million shares on the day, lower than the company’s 50-day daily volume of 64.79 million and below its year-to-date volume of 35.78 million. CLOV stock retreated by 16.10% in the past year and has risen by 8.10% in the last week. CLOV stock has lost a total of -14.88% over the last six months, and it has gained 6.66% in the last three months. CLOV stock is up ahead of a virtual conference at which it will present.
CLOV Stock will be presenting where?
Clover is a next-generation risk-bearing organization aiming to achieve health equity for all Americans. While its mission is to improve every life, CLOV particularly focus on seniors who have historically lacked access to affordable high quality healthcare.
KeyBanc’s Virtual Technology Leadership Forum will feature presentations by Clover executives. During the presentation on Thursday, August 12 at 2:00 pm Eastern Time, executives from CLOV will be on hand. CLOV’s investor relations website will provide a live webcast of the presentation. Following the live presentation, the CLOV website will host an archived recording of the presentation.
A new strategic partnership has been formed between Clover and ValueH, a leading member organization focused on Value-Based Care.
- Beginning in 2022, ValueH will provide support to Accountable Care Organizations (ACOs) and management services organizations (MSOs) taking part in CLOV’s Direct Contracting Entity (DCE).
- CLOV’s DCE will allow providers to manage their Original Medicare patients’ care through the Clover Assistant.
- In addition to its clinical utility, Clover Assistant is a data-driven, personalized recommendation system used by doctors at the point of care to help them improve their patient care.
- Participants can take advantage of Unified, Actionable Data, Personalized Care Plans, and Simple, Fast Reimbursement with the Clover Assistant.
- CLOV’s partnership with ValueH will help promote the growth of value-based models for Medicare patients, specifically, while also helping to lower medical costs because value-based contracts have the potential to raise the quality of care provided to patients.
Potential of CLOV’s DCE:
Since it started participating in the Global and Professional Direct Contracting Model of the Centers for Medicare & Medicaid Services, Clover Health (CLOV) partners has experienced significant growth as a DCE. Claims alignment for CLOV’s beneficiaries amounted to over 65,000 claims as of April 1, 2021, and the company contracted with approximately 1,800 providers across eight states.
